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Surface  biofunctionalization,  including  chemical  activation  and  attachment  of  the
bioreceptor, is an essential step to provide reliable detection of biomolecular binding
events monitored by Surface Plasmon Resonance (SPR),  the  most  employed optical
biosensor, and other biosensor techniques. Recent progress in the area of immobilization
procedures  are  aimed  at  producing reproducible  interfacial  surfaces  that  enable  the
sensitive and specific recognition of the analyte. Antibodies are still the most employed
bioreceptors  for  SPR  assays.  A  wide  range  of  strategies  have  been  proposed  to
maximize  the  SPR  immunosensor  performance  by  controlling  the  stability  and
orientation  of  the  immobilized  antibody.  This  article  reviews  the  most  recent
advancements  in  random and oriented antibody immobilization  approaches  for  SPR
biosensing applications, with a special focus on the research that have been done to find
universal  linkers,  which  can  allow  the  use  of  the  same  functionalized  surface  for
different applications. 
Keywords: SPR;  biofunctionalization;  antibody  immobilization;  special
immunosurfaces
1. Introduction
The interest on Surface Plasmon Resonance (SPR) biosensor as a label-free tool for
monitoring binding events in real time has been growing exponentially since the first
publications expanding to clinical, environmental and food analysis applications [1-2].
Although SPR technology primarily focused on the improvement of the design and the
miniaturization of the technological platforms [3], the feasibility of high performance
SPR devices  relies  mostly  on  the  correct  incorporation  and functionalization  of  the
biological receptor recognition layer [1]. 
SPR  biosensors  commonly  use  antibodies  as  bioreceptors  to  recognize  its
complementary target. Although recent progress in biotechnology have led to the design
of new recognition molecules as aptamers or imprinted polymers [4], theoretically able
to  replace  antibodies,  antibody-based  assays  are  still  the  first  choice  for  studying
biomolecular  interactions  due  to  their  superior  performance.  The  production  of
antibodies can be directed against a large variety of molecules ranging from low to high
molecular weight, as pesticides, hormones drugs and intact cells. Antibody production
can be dedicated and expensive but the excellent properties of antibodies like affinity,
selectivity  and  stability  make  immunoassays  one  of  the  most  robust  molecular
biorecognition systems.
The  selection  of  the  immunoassay  format  frequently  relies  upon  the  nature  and
characteristics of the analyte which has to be determined. In a typical enzyme-linked
immunosorbent  assay  (ELISAs)  antibodies  need to  be  labeled  in  order  to  obtain  a
detectable signal, whilst immunosensors as SPR allow direct determinations in real-time
without the need of labels or additional steps [5]. Monitoring of immunoresponses by
SPR biosensor can be obtained by using either the antigen or the antibody as ligands.
For analytes with a molecular weight over 1000 Da, the use of antibodies as ligands is
preferred so that the antibody immobilized onto the sensor surface may recognize its
complementary antigen in a simple, fast and direct manner. 
A number  of  immobilization  models  have  been  reported  for  the  achievement  of
maximum  immunosensor  consistencies  while  preserving  the  biological  activity  of
immobilized  antibodies.  The  immunosurface  stability  is  crucial  since  it  prevents
antibody  denaturation  and  non-specific  binding  during  the  immunointeraction.  The
formation of well-ordered interfaces without damage of the immobilized antibodies is
also  an  essential  aspect  for  the  achievement  of  reliable  and  sensitive  biosensor
platforms. The search for a universal immobilization method is still beyond our reach
and many new immobilization techniques have been studied during the last years to
achieve  this  goal.  Figure  1  shows  common  and  recent  developments  of  surface
biofunctionalization strategies.
Immobilization designs can exploit random or orientated formats in order to obtain the
maximal functionality by enhancing the immunosensor capacity and/or the orientation
of  the  antibody  binding  sites. Discussion  on  random  and  orientated  antibody
immobilization strategies has been addressed in some studies [6]. In general, random
immobilization formats succeed in achieving higher surface coverages while strategies
based on the orientation of antibodies provide better sensitivities for analyte detection.
Random orientation of antibodies can be affected by steric hindrance and non-specific
protein  adsorption,  resulting  in  antibody  inactivation  and  lowest  antigen  binding
capacity [7]. As a consequence, the oriented immobilization of antibodies, from site-
directing methods to  protein-binding proteins,  is preferable since it  affords chemical
stability and optimal availability of the functional groups. The analytical performance
between several random and oriented immobilization strategies is compared in Table 1.
The  concern  on  the  value  of  selecting  the  appropriate  immobilization  method  for
measuring  antigen-antibody  interactions [8] is  demonstrated  by  the  number  of
publications released every year.  This review focuses on the recent advances of SPR
immobilization strategies for immunoanalytical formats. In particular,  we concentrate
on the current trends based on the combination of traditional and novel biotechnological
alternatives,  like  fusion  proteins,  polymer  brushes  and intact-fragmented  antibodies,
recently developed for the design of universal interfaces. Special attention has been paid
to the functionalization of SPR biosensor surfaces with major applications in clinical
diagnostics and real-time analysis.
2. Antibody immobilization formats
The  classification  of  strategies  for  the  immobilization  of  antibodies  onto  both
unmodified and previously functionalized gold substrates is difficult due to the diversity
of activation processes and the singularity of each recognition event.  The following
allocation  refers  to  both,  the  method in  which  the  antibody is  linked to  the  sensor
surface and the specific characteristics of the immunological interaction.
2.1. Adsorption
Direct adsorption onto gold surfaces by electrostatic forces has been the most employed
antibody  immobilization  approach  for  decades.  This  method  is  simple  and  easy  to
perform. However, physical adsorption is an uncontrolled and non-specific process that
may cause the inactivation and denaturation of immobilized antibodies. Consequently,
the stability and the reproducibility of the assay decay. 
During last years, some studies have reported the efficiency of different immobilization
strategies by comparing physical adsorption with covalent coupling, specific adsorption
via biotin orientation [9] or carbon nanotubes [10]. In spite of its clear disadvantages,
physical adsorption in SPR sensors has been recently applied in clinical diagnostics for
the detection of the tuberculosis antigen CFP 10 and the human fetuin A biomarker [11,
12].  Nevertheless,  non-specific adsorption of antibodies on SPR sensor surfaces has
proved  to  be  the  least  sensitive  and  reliable  immobilization  method  due  to  the
conformational changes,  steric hindrance and inappropriate orientation caused by the
direct contact of antibodies with the metal surface.
2.2. Covalent coupling by Self-assembled monolayers
Covalent  binding  of  antibodies  to  previously  chemically  modified  substrates  is  the
immobilization  format  most  commonly  employed  for  monitoring  antigen-antibody
interactions. 
In particular, self-assembled monolayers (SAMs) of alkanethiolates are suitable for the
immobilization  of  a  wide  variety  of  biological  molecules.  The  antibody  attachment
through SAMs provides stable and ordered layers that reduce non-specific adsorptions
[7].The formation  of  SAMs is  simple  and reproducible.  Afterwards,  the  antibody is
covalently cross-linked to the SAM. Gold thiol monolayers typically consist of alkyl
thiol  chains  of  11  to  16  carbons  that  allow  the  antibody  coupling  to  a  chemically
activated surface by using a mixture of N hydroxysuccinimide (NHS) and 1-ethyl-3(-3-
dimethyl-aminopropyl)  carbodiimide  hydrochloride  (EDC).  In  the  reaction,  EDC
converts  the  carboxylic  acid  of  the  alkanethiol  into  a  reactive  intermediate  (N-
hydroxysuccinimide ester), which is capable of attaching covalently the amine groups of
the  antibody. Due  to  its  versatility,  SAMs  have  been  successfully  employed  in
numerous  bioanalytical  applications  ranging  from  cancer  biomarkers  detection
(carcinoembriogenic antigen) [13] to on-line determinations of cell suspensions [14]. 
The search for robust and reliable immobilization protocols introduced variations to the
common alkanethiolated SAMs technique. One common approach is the use of mixed
layers of thiols.  [15].  Mixed thiols SAMs take advantage of the difference in chain
length to enhance the orientation of the immobilized antibodies while minimizing non-
specific  adsorption.  The  formation  of  mixed  SAMs  typically  includes  one
functionalized alkanethiolate with a carboxylic acid ending group at a low mole fraction
and a non-functionalized thiolate of lower chain length at a high mole fraction [7]. The
combined  presence  of  both  thiol  types  reduces  steric  hindrance  by  providing  the
appropriate concentration of functional groups [15].
Last  trends  in  SAM  based-immobilization  models  employ  oligo-  or  poly-ethylene
glycols  (OEG  or  PEG)  as  spacers  to  enhance  the  assay  sensitivity  [16]. The
functionalization of gold substrates based on polythiols, PEG and thiol-peptides [17]
exploits the linkage between amine and thioacetal groups to form stable monolayers. In
particular,  PEG  SAMs  prevent  nonspecific  adsorption  of  proteins  due  to  their
antifouling capacity to overcome undesirable steric effects [18]. Their flexibility and
hydrophilic  properties  generates  the  appropriate  environment  to  avoid  non-specific
adsorption by both the compression and the presence of water molecules around PEG
chains. Several variations of this model like the reaction of alkyl or polyoxyethylene
chains  with  either  silane  or  NHS  groups  have  also  been  used  for  the  covalent
immobilization of antibodies. Likewise, the assemblage of peptide linkers [19] to SAMs
and the application of dendrimer technology to the fabrication of nano-scale SPR sensor
chips  are  other  interesting  approaches  to  improve  the  antibody  orientation  on  SPR
platforms.  Specifically, dendrimer  macromolecules  consisting  of  a  tridimensional
architecture of hyperbranched polymers have been successfully applied to the design of
nanohybrid Ag/Au structures  [20].  In  the  same way,  the  potential  of  dendrimers  as
detecting agents has been exploited for the construction of conjugated systems with
application in clinical diagnosis of allergy processes [21]. 
Finally,  covalent  attachment  of  antibodies  by  self-assembly  technology  has  been
associated with other immobilization techniques in order to obtain more feasible and
reliable methods for the functionalization of gold substrates. Most of them compare the
efficiency in terms of coverage and sensitivity with other strategies. For instance, SAM
technology  has  been  used  in  combination  with  specific  adsorption  by  avidin-biotin
binding [9,  22]  (see  Fig.2),  poly-brushes  [23]  or  protein  binding proteins  [24,  25].
Numerous examples of this type of SAM-based immunosensors have been published
over the last few years. As shown in Table 1, better sensitivity and selectivity values are
obtained  for  SAMs  involving  oriented  immobilization  formats  and  non-fouling
biosurface  designs.  The  combined  use  of  oriented  and  non-fouling  surfaces  may
enhance both antibody binding capacity and availability. Further information is given in
the respective sections. Further information is given in the respective sections.
2.3. Oriented immobilization by antibody binding proteins
 Functionalization of immunosurfaces via Protein A and Protein G binding is a common
strategy to achieve site-oriented immobilization of antibodies. It consists primarily of an
antibody  binding  protein  coated  surface  that  selectively  captures  the  Fc  region  of
antibodies leaving Fab bioactive sites free for the antigen specific interaction.  Since
Protein A and G contain 4-5 and 2-3 IgG binding domains respectively, antibodies can
be properly orientated without the need of prior alteration and regardless the protein
orientation. The result is a stable and sterically accessible immunosurface that preserve
the antibody ability to recognize specifically its complementary target.
Antibody binding proteins are generally attached to gold-coated surfaces via thiolated
SAMs or Dextran-Hydrogel coupling.   Alternatives to  traditional linking layers may
involve protein modifications that provide reliable environments for SPR monitoring.
For instance, Protein G can be chemically and genetically engineered [26, 27] to contain
thiolate  or  cysteine  residues.  The  addition  of  these  groups  contributes  to  the
enhancement of immobilized antibodies with regard to non-chemically modified Protein
G layers [28].  For instance,  amine groups from lysine residues in protein G can be
converted to thiol groups with 2-iminothiolane leading to the direct formation of a self-
assembled protein G layer and the subsequent attachment of antibodies through their
nonantigenic regions. Similarly, Protein G bound to magnetic particles has been used
with this aim to improve antibody orientation [29]. 
On the other hand, Protein A has been employed to construct complex bionanostructures
by  being  assembled  to  gold  binding  proteins  [30,  31]  and  biotin  tags  [32].  These
procedures result in the formation of well-ordered layers that increase the accessibility
of  antigens  to  the  antibodies  binding  sites  avoiding  undesirable  effects  of  steric
hindrance. 
Another  interesting  approach  is  the  autodisplay  technology.  This  method  has  been
broadly used in recent years to express the Z-domains of protein A with IgG binding
activity  as  a  fusion  protein  at  the  outer  membrane  of  Escherichia  coli and
Staphilococcus  aureus.  The  assay  sensitivity  can  be  improved  by  the  controlled
orientation of the Z domains [33]. Recently, E.coli cells with autodisplayed Z domains
have also been associated with magnetic beads [34], nanocapsules [35] and chemically
activated parylene films [36]. The increasing number of SPR studies on autodisplaying
of Protein A, Z domains suggests that this trend may be interested to construct more
stable and sensitive antibody-based analytical platforms. 
2.4.  Biotin-avidin specific adsorption
The immobilization of  antibodies via  biotin-avidin  coupling is  a  common choice  to
control the effect of receptor orientation in immunosurfaces. The biotin-avidin system
provides high stability and physico-chemical resistance to the immobilized antibodies.
Biotin  can  be  bound  to  a  wide  range  of  macromolecules  (proteins,  peptides,
oligonucleotides and antibodies) while maintaining its binding affinity towards avidin or
avidin-related molecules such as streptavidin or less frequent concanavalin, neutravidin
and catavidin [37-39]. Taking advantage of its four binding sites, streptavidin form a
layer  over  a  biotynilated  surface  with  capacity  to  capture  more  efficiently  the
biotynilated  antibody.  The  biotin-streptavidin  binding  can  be  easily  disrupted  by
regeneration  solutions  allowing  the  repeated  use  of  the  same  biotynilated  surface.
However,  one  meaningful  limitation  is  the  need  of  modifying  chemically  the
biotynilated antibody thus increasing both the time and the cost of the analysis.
The search for original analytical developments has led to the use of combined biotin-
streptavidin immobilization approaches. SPR more striking designs include the use of
polymers  for  the  construction  of  copolymer  films  of  polypyrrole  layers  in  the
functionalization  of  single-chain  antibodies  and  the  development  of  biotin  tagged
glycopolymers for antibodies detection [40, 41]. 
The capacity of biotin-avidin complexes to orientate antibodies has been exploited in
combination with non-specific adsorption or SAM-based covalent coupling to compare
the  efficiency  of  the  immobilization  process.  Additionally,  several  new applications
involving Protein G layer surfaces [42], biotin tagged aptamers [4] and single domain
antibodies  random-  and  site-specifically  biotynilated  have  been  tested  to  assess  the
sensitivity of different immobilization methods [38]. Other singular approaches include
the assembly of biotynilated Protein A/G and Fc antibody fragments [32].
2.5. 3D surfaces: Polymer supports
The functionalization of the gold SPR sensor via polymers provides a  versatile  and
heterogeneous 3D matrix for the entrapment of antibodies by adsorption, diffusion or
covalent coupling. The antibody is immobilized in a controlled environment that assures
its binding capacity and recognition properties under non-denaturing conditions. 
Polymer-based platforms have been traditionally  used in  SPR biosensing,  especially
through Biacore CM5 dextran-hydrogel sensor chips.  Dextran-based hydrogels are  a
common alternative to the covalent attachment of biomolecules. The main difference
between dextran and thiolated SAMs is the concentration of immobilized ligands. The
special conformation of dextran based-layers provides multiple binding sites permitting
a high density of immobilized receptors. On the other hand, SAMs attain ultrathin layers
that offer better control over the recognition capacity of the functional groups. Although
both  methods  fail  in  offering  optimal  control  for  the  oriented  immobilization  of
molecules,  thiolated  SAM  technology  supplies  much  more  ordered  structures  than
hydrogels due to its flexibility and capacity to orientate the immobilized antibody in
size and functionality while dextran hydrogels provide larger immobilization interfacial
matrices  [37].  In  particular,  carboxymethyl  dextrans  produce  thicker  functionalized
layers (100nM) [43] that enable the covalent binding of the positively charged amine
groups  of  antibodies  to  the  ending  carboxylic  groups  of  the  dextran,  previously
activated by a carbodiimide bonding. 
Chemical variations to dextran hydrogels have been reported in recent years in order to
obtain more efficient 3D networks. Among polymer supports currently available, the
use of glycopolymer based on polyacrilamide hydrophobic compounds [44] have played
a  significant  role  as  multi-dimensional  surface  matrices.  For  instance,  methyl
acrylamide  polymers  have  been  used  in  sandwich  assays  to  detect  Human  IgG  in
combination  with  colloidal  gold  [45]. The  spaced glycopolymer microarray  showed
enhanced lectin (Arachis hypogaea) binding compared to a non-spaced one [46].
 Furthermore,  the  number  of  studies  involving  parylene  coating  has  increased
significantly over  the  last  years.  The construction  of  parylene  films consists  on the
deposition of poly (p-xylylene) polymers by chemical vapor on SPR sensor chips. The
efficiency of parylene polymers for improving the capture of antibodies has been proved
to be 20 fold higher than 2D glass surfaces [47]. The detection range and sensitivity of
several SPR applications based on parylene H with formyl groups is superior to other
immobilization formats [48].  The autodisplaying technology of  Z domains has been
successfully  used  in  combination  with  parylene  H coating  on  medical  diagnosis  of
inflammatory diseases. Likewise,  covalent attachment of biomolecules has also been
tested by the incorporation of primary amine groups on a parylene A film used as a
linker layer and the coating of SPR sensor chips with hydrophilic carboxylic terminated
polymer matrices [43]. A variation of polymer surfaces for immunosensing applications
are copolymers of polypyrrole propilic acid films [49]. Electropolymerized copolymers
of  polypyrrole  provide  relevant  information  on  the  efficiency  of  SPR  and
electrochemical  analysis  of immunosensing events and the characterization of  redox
activity for detecting specific associations. The search for low-fouling substrates that
diminish non-specific adsorptions has triggered the development of polymer brushes of
(poly(2-hydroxyethyl  methacrylate)  (poly  (HEMA))  and  poly[oligo(ethylene  glycol)
methacrylate-co-glycidyl  methacrylate]  (POEGMA-co-GMA))  as  valuable  tools  for
increasing the immobilization area of SPR sensor chips [50]. SPR applications based on
poly-brushes  exploit  the  non-fouling  properties  of  these  configurations  to  provide
densely packed surfaces with minimal thickness in order to obtain most sensitive assays
for  clinical  diagnosis  and  biological  research  [10,  23].  Zwiteronic  carboxybetaine
polymers  have  also  emerged  as  low-fouling  agents  to  functionalize  SPR substrates
enabling  the  detection  of  analytes  in  complex  media  such  undiluted  human  blood
plasma [51].
The  use  of  calixarene,  a  well-known protein  artificial  receptor,  as  linker  system to
biofunctionalize SPR sensor surfaces has been recently addressed.  The formation of
calixarene crown ether monolayers allow the selectivity and reliability of SPR assays
while resembling experimentally native conditions [52]. The most common calixarene
commercial  application,  ProLinker™,  has  proved  to  be  more  efficient  in  orienting
antibodies when compared with other immobilization strategies like protein G and SAM
covalent attachment [53] (see Fig. 3).  In like manner, site directed immobilization of
antibodies  through  conducting  polymer  substrates  of  polyamic  acid  have  also  been
investigated to achieve well-orientated immunosurfaces. 
The combination with other immobilization formats have permitted the use of polymers
as  stabilizers  of  antibody  fragments  coated  on  colloidal  gold  nanoparticles  [45].
Additionally,  polymers  can  contribute  to  reduce  non-specific  binding  by  using
molecular  layers of Fab antibody fragments intercalated with non-ionic polymers or
non-fouling polymers in combination with photoreactive crosslinkers. 
Other  immobilization  approaches  have  reported  polymer  supports  as  chitosan
composites of silver nanoplates [54], cellulose membranes [55] polyestirene substrates
[56]  and  thiolated  polymers  [57]  which  have  been  also  used  as  supports  for  the
immobilization of antibodies. 
2.6.  Fragmented antibodies
Coupling strategies may involve antibody modifications [6-38] (see Fig.4).  Particularly,
antibodies can be chemically fragmented or genetically engineered to use only the Fab
fragment  containing  the  antigen-binding  domain.  The  immobilization  of  antibody
fragments provides the appropriate site-specific orientation of the antigen binding Fab
domains while contributing to increase the accessibility for analytes and the antigen-
antibody binding capacity [58]. Antibody fragments obtained from intact antibodies by
enzyme digestion and chemical reduction contain free sulfhydryl groups that can be
employed for either their direct immobilization on the gold surface or their  chemical
cross-linking to a previously activated SPR sensor chip [59].
The immobilization via their native thiol groups have been traditionally reported for
direct antibody coupling to the gold surface [6]. More recently the functionalization of
gold  nanoparticles  with  antibody  fragments  has  been  exploited  to  enhance  the
sensitivity  of  SPR-based  assays  [45,  59].  The  activation  of  sensor  chips  by  Au-S
linkages assures appropriate steric conditions while reducing hindrance and producing a
20-fold rise of antibody binding capacity [8].
Other  works  describe  the  use  of  single  chain  variable  (scFv)  and  Fab  fragments
engineered by recombinant  antibody technology [38].  Most  frequent  applications  of
recombinant technology involve: antibody tagging of hystidine and cysteine residues
introduced at the end of the antibody fragments [60] and fusion proteins obtained from
the connection of the variable regions of the heavy and light chains with a short linker
peptide.  Both  genetically-engineered  antibody  modifications  are  directed  to  the
construction  of  a  controlled-orientated  antibody  density  onto  the  sensor  surface.  A
singular usage of recombinant technology is the fabrication of bispecific antibodies to
functionalize gold substrates. Bispecific antibodies consist of fragments of two different
monoclonal  antibodies  that  can  recognize  two  different  types  of  antigens.  SPR
applications include the simultaneous determination of inflammatory biomarkers [62].
The combination of Antibody fragments with other immobilization strategies have been
investigated in several applications which include the avidin-streptavidin system [38],
polymer modified-surfaces and protein binding proteins formats [32] as shown in Fig. 1.
2.7. Gold coated nanoparticles and nano-surface modifications
Gold nanoparticles are one of the most extended strategies to enhance the sensitivity of
SPR-based assays.  Physical and chemical properties of gold nanoparticles have been
primarily exploited for the immobilization of antibodies.  For instance, conjugates of
antibody fragments and gold nanoparticles have been used to improve the functionality
and stabilization of SPR assays solely [59] or in combination with intercalated polymers
[45]. 
Recent applications involving novel antibody immobilization formats use gold-coated
magnetic nanoparticles and nanocomposites of magnetic gold nanorods [9, 63]. Other
approaches employ gold nanoparticle-antibody conjugates either for the characterization
of  the  bioconjugation  process  or  for  the  detection  enhancement  by  incorporating
graphene oxide layers to the functionalized surface area [64, 65].  
A number  of  publications during last  years  also  describe  localized surface  plasmon
resonance  properties  of  gold  nanoparticles  of  all  type  of  shapes  and  sizes  for  the
improvement of plasmonic biosensors performance. Likewise, the use of nanosurface
modifications  such  as  multi-  or  single  walled  carbon  nanotubes  platforms  [10],
graphene  or  graphene  oxide,  nano-gratings,  nano-patterned  surfaces  and  nanohole
arrays have also been considered to enhance the sensitivity of the SPR response [66].
2.8.  Other strategies
Oher  alternative  immobilization  methods  as  fusion  proteins  have  been  successfully
applied to achieve reproducible immunodetection formats.  Most frequent approaches
are  based  on  recombinant  genetic  techniques  in  order  to  obtain  gold  binding
polypeptides  (GBP)  with  the  capacity  of  directly  anchoring  to  gold  surfaces  [67].
Genetically engineered proteins have allowed the direct binding to the gold substrate by
fusing  to  single  chain  fragmented  antibodies.  Fusion  proteins  of  Protein  A  and
concanavalin-Streptavidin  formats  have  also  been  produced  in  Escherichia  coli to
provide effective antibody immobilization [30-31, 68].
An interesting approach is the application of DNA-directed antibody immobilization
procedures  that  consist  on  the  hybridization  of  single  stranded  DNA-antibody
conjugates  to  complementary  DNA sequences  previously  immobilized  on  the  gold
surface  [69].  DNA-antibody  hybrids  are  fabricated  by  chemical  synthesis  of
oligonucleotides covalently  coupled  to  specific  antibodies  directed  against  a  target
analyte.  This  method  provides  sensitive  and  flexible  surfaces  to  construct  protein
receptor layers. Moreover, by using this immobilization approach SPR monitoring may
also  provide  detection  of  molecular  and cellular  interaction  events  occurring  at  the
sensor surface [70]. 
Other  significant  examples  are  the  construction  of  SPR  platforms  based  on  aryl
dizonium electrographting to achieve a significant improvement in antifouling coatings
[71].  Pairwise  antibody  footprinting  is  also  a  relevant  approach  for  the  direct
immobilization of antibodies to block the unoccupied immobilized anti-Fc to prevent
non-specific antibody binding [72]. Distinct methods ranging from kinetic studies of
antibodies immobilized into liposomes to straightforward antibody immobilization via
immersion in dithiocarbamate solutions have been studied for the construction of rapid
and direct immobilization methods [73, 74]. 
3. Conclusions
The increase of the number of applications which can be reached by SPR biosensors has
triggered  the  search  for  versatile  and  reliable  immobilization  protocols.  The
investigation  on  novel  immune  receptor  surfaces  has  growth  in  parallel  with  the
progress of genetic engineering and the expansion of biomaterials science to produce
stable biological supports. Among them, antibody-based bioreceptors systems lead the
query of universal linkers for immunodetection assays.
In  spite  of  the  need  for  a  general  method,  conventional  antibody  immobilization
strategies seem to rely on the particular features of each assay system. One of the most
controversial  debates  is  the  random  versus  orientated  immobilization  format.
Investigation  on the  subject  suggests  significant  benefits  of  oriented immobilization
formats for improving assay selectivity. The construction of non-fouling receptor layers
is also an interesting step in order to avoid non-specific adsorptions while preserving
antibody  properties.  Comparison  between  immobilization  strategies  suggests  that
antibody orientation provides more sensitive detection assays whereas superior surface
densities are obtained by random covalent immobilization formats.
Although a universal immobilization method has not yet figured out, advancements in
biological  interfaces  may  contribute  to  achieve  better  outcomes  regardless  the
singularity  of  the  assay  format.  Current  immobilization  formats  take  advantage  of
progress  in  chemically  modified  biosurfaces  for  the  construction  of  high  feasible
bioreceptor layers. Furthermore studies on activity, thermodynamic and kinetic binding
parameters may also provide a valuable background to improve the efficiency of SPR
biosensor surfaces.  
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Fig. 1. Novel immobilization strategies based on combinations of common and recent developments of surface functionalization.
Fig. 2 (a) Sensorgrams obtained for covalent immobilization ofendostatin on a 1 mmol L−1 SAM–MHDA (99% pure 16-MHDA) sensor chip (solid
line), a control flow cell lacking endostatin (dashed groups by injection of EDC–NHS for 600 s, injection of endostatin in 10 mmol L−1 maleate buffer
pH 6 (solid line) or of maleate buffer alone (dashed line) for 600 s, injection of 1 mol L−1 ethanolamine pH 8.5 for 600 s, two injections of HBS-P+for
60 s each (data not shown). All steps were performed at 5 μL min−1 and sharp increases in the SPR signal were because of changes in refractive index.
(b) Injection of a polyclonal anti-endostatin antibody (162.5 nmol L−1) over immobilized endostatin on different sensor chips at 30 μL min−1 (after
subtraction of the non-specific SPR signal measured on the control flow cell). The arrows indicate the beginning and the end of the IgG injection
(Reprinted from [22] with permission from Springer).
Fig. 3.  (a) Comparison of antibody immobilizations at different antibody concentrations (5, 10, 20, 50, 100 μg/mL) with different strategies. Grey:
covalent strategy; Green: Protein G strategy ([Protein G] = 50 μg/mL); Purple: ProLinker™ strategy; (b) Antigen detection performed with hCG/anti-
hCG for covalent strategy (black), Protein G strategy (green) and ProLinker™ strategy (purple). Concentration of anti-hCG antibody was 10 μg/mL in
all cases. Dashed lines represent adsorption of nonspecific proteins onto antibody functionalized surfaces for covalent strategy (black), Protein G
strategy (green) and ProLinker™ strategy (purple). Blue dotted line indicates additional control for the ProLinker™ strategy, based on the detection of
hCG onto a nonspecific antibody (10 μg/mL) immobilized over ProLinker™ layer (same experimental conditions as with specific antibody). (Reprinted
from [53] with permission from MDPI).
Fig. 4.  (A) The SPR-signals obtained by differently modified SPRchips. (B) Equilibrium angle dependence from antibody immobilization technique: a, MUA/intact-anti-
HGH; b, CMD/intact-anti HGH; c, MUA/ pG/intact-anti-HGH; d, Au/frag-anti-HGH. The HGH concentration in all tested samples was the same: 1.59 μM. Reprinted from
[6] with permission from Royal Chemical Society).
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NPs: nanoparticles; Ab: antibody PBSE: 1 pyrenebutanoic acid succinimidyl ester; MHDA: 16 mercaptohexadecanoic acid; EGhexa ethylene
glycol undecanethiol; Strept: streptavidin; frag.: fragment. Source: Antibody immobilization SPR (ISI WEB of Knowledge)
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Please find enclosed our manuscript entitled ‘Towards the design of universal
immunosurfaces  for  SPR-based  assays:  a  review’, that  we  wish  to  submit  for
publication in TrAC Trends in Analytical Chemistry.
This  work  reviews  recent  advances  of  SPR  immobilization  strategies  for
immunoanalytical formats. In particular, we concentrate on the current trends based on
the  combination  of  traditional  and  novel  biotechnological  alternatives,  like  fusion
proteins, polymer brushes and intact-fragmented antibodies, recently developed for the
design of universal interfaces. Special attention has been paid to the functionalization of
SPR biosensor surfaces with major applications in clinical diagnostics and real-time
analysis.
In  comparison  with  previous  reviews  this  work  provides  additional  and  relevant
results  on  the  the  search  for  versatile  and  reliable  immobilization  protocols. Our
approach  may  also  be  useful  in  designing  chemically  modified  biosurfaces  for  the
construction  of  high  feasible  bioreceptor  layers.   Therefore,  we  think  that  our
contribution is in the scope of your journal.
Yours sincerely,
Elba Mauriz, Ph.D.  
 The value  of  selecting the  appropriate  immobilization  method  for measuring
antigen-antibody interactions.
 Recent  advances  of  SPR  immobilization  strategies  for  immunoanalytical
formats.
 Current  trends  based  on  the  combination  of  traditional  and  novel
biotechnological alternatives. 
 Functionalization of SPR biosensor surfaces with major applications in clinical
diagnostics and real-time analysis.
Dear Editor,
I  am  writing  to  you  regarding  the  referees’  comments  to  the  manuscript  entitled
‘Towards  the  design  of  universal  immunosurfaces  for  SPR-based  assays:  a
review’. We sincerely apreciate the comments. In response to the queries, we have
revised the manuscript paying special attention to the referees’ requests. 
We hope that the revised version can fulfil  the requirements for publication in your
journal.
Sincerely yours,
Dr. Elba Mauriz 
Referee´s comments
The  submitted  manuscript  reviews  the  recent  progress  regarding  surface
biofunctionalization techniques applied to SPR biosensors. The contribution discusses
about a wide range of proposed strategies to increase the biosensor performance, to
control  the  stability  and  antibody  orientation,  and  also  discuss  the  possibility  of  a
universal immobilization method. 
In order to increase the knowledge of the surface biofunctionalization strategies and
SPR biosensors,  this  paper  has  an  appropriate  approach  suitable  for  this  journal.
Likewise, the submitted paper shows a good literature review and it  is well  written.
Therefore, I recommend its acceptance. However, 
I  would  like  to  comment  some  details  to  the  authors  in  order  to  improve  the
contribution:
1. Abstract. The authors say: “Surface biofunctionalization…, is an essential step
to  provide  reliable  detection  of  biomolecular  binding  events  monitored  by
Surface Plasmon Resonance (SPR), …”. Of course this statement is true, but I
consider  that  a  successful  surface  biofunctionalization  is  crucial  for  all  the
biosensor techniques, not only SPR.
Response:  We  agree  with  the  referee´s  comment.  As  he/she  mentiones  surface
biofunctionalization  is  essential  for  all  types  of  biosensor  devices.  Following  the
referee’s suggestion, we have modified the sentence and we have added ‘and other
biosensor techniques’ to the sentence.
2. Introduction, 3rd paragraph. From this paragraph I understand that 1KDa is the
limit of sensitivity of the technique. Is that correct?
Response:  The level  of  sensitivity  of  1KDa applies only  when SPR employs direct
detection  formats  for  the  monitoring  of  binding  events.  However,  lower  limits  of
detection for molecules below 1 KDa have been broadly achieved by using binding
inhibition assays involving the antigen immobilization.
3. Figure 1. The figure is not complete in the submitted version (the bottom left
part is missing).
Response: We are sorry for the error. We have corrected it in the revised version.
4. Table 1.  I  do  not  understand the comparison of  the analytical  performance.
Which application is the most sensitive, the fastest?
Response:  The  purpose  of  the  Table  is  to  report  the  application  of  different
immobilization methods for the detection of the same analyte by comparing several
analytical parameters. Since results depend on the specific characteristics of the
target analyte it is difficult to extract general conclusions from the data compared.
However, it  is possible to consider that antibody oriented formats provide better
sensitivity  and  selectivity  values,  while  polymer  supports  increase  biosurfaces
densities. In order to improve the understanding of these aspects, the following
sentences have been added to the last paragraph of section 2.2.: ‘As shown in
Table 1, better sensitivity and selectivity values are obtained for SAMs involving
oriented immobilization formats and non-fouling biosurface designs. The combined
use  of  oriented  and  non-fouling  surfaces  may  enhance  both  antibody  binding
capacity and availability’.
5. Reference 53 is not correctly written.
Response: Reference 53 has been corrected.
6. Conclusions,  2nd paragraph.  The authors say:  “Investigation on the subject
suggests significant benefits of oriented immobilization formats for improving
assay selectivity”.  From  the  Section  2.3  I  understood  that  the  oriented
immobilization improves the sensitivity, instead of the selectivity.
Response:  We think that  the referee’s observation is in  line with  the discussed
statement since the specificity provided by well-ordered antibody oriented surfaces
also causes the improvement of the assay sensitivity. In particular, our sentence
refers to the use of non-fouling surfaces that avoid the undesired adsorption of non-
specific biomolecules.
